Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_assertion type Assertion NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_head.
- NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_assertion description "[In addition, collaborative studies of BMPR2 mutation carriers should enable identification of environmental modifiers, biomarkers for disease development and progression, and surrogate markers for efficacy end points in clinical drug development, thereby providing an invaluable resource for trials of PAH prevention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_provenance.
- NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_assertion evidence source_evidence_literature NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_provenance.
- NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_assertion SIO_000772 19555857 NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_provenance.
- NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_assertion wasDerivedFrom befree-2016 NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_provenance.
- NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_assertion wasGeneratedBy ECO_0000203 NP747523.RABC06EukadKnb-vjZa6JMhtzDd0YSfsKYAJVX1CcFB-c130_provenance.